GeneDx Holdings (WGS) Treasury Shares (2021 - 2026)

GeneDx Holdings has disclosed Treasury Shares across 6 years of filings, most recently posting $1.7 million for Q1 2026.

• In Q1 2026, Treasury Shares fell 8.06% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (down 8.06% YoY), while the FY2025 annual figure was $1.5 million, down 18.71% from the prior year.
• Treasury Shares advanced to $1.7 million in Q1 2026, from $1.5 million in the prior quarter.
• Over the last five years, Treasury Shares for WGS reached as high as $23.7 million in Q3 2022 and fell as low as $855061.0 in Q4 2022.
• The 5-year median for Treasury Shares is $1.8 million (2025), against an average of $4.9 million.
• Annual changes were most pronounced in 2022 — Treasury Shares sank 93.21% — and 2023, when it jumped 76.35%.
• A 5-year view of Treasury Shares shows it stood at $855061.0 in 2022, then jumped by 76.35% to $1.5 million in 2023, then grew by 23.99% to $1.9 million in 2024, then slipped by 18.71% to $1.5 million in 2025, then rose by 8.72% to $1.7 million in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $1.7 million, $1.5 million, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.